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Dear Sir
We have read with interest the study entitled BEfficacy of
First-Time Intragastric Balloon in Weight Loss: a Systematic
Review and Meta-analysis of Randomized Controlled
Trials^ [1].
Meta-analyses of randomized controlled trials are the
most valuable source of our knowledge, because results
can be generalized to a larger population. Usually, they
are the background for practicing surgeons when decid-
ing which type of treatment could be the best choice
offered to the patient. For this reason, we are convinced
that such studies should be performed on the basis on
currently available methods of treatment and medical
devices used today.
Therefore, we are surprised that the abovementioned study
involves historical or experimental types of intragastric bal-
loon which have not been applied for more than 20 years. We
found that this concerns 8 studies from the total number of 20
studies included by the authors in their analysis (Table 1).
What is also worth mentioning is that the population of pa-
tients included in the studies with historical devices accounts
for 24% (n = 289) of the whole population of patients involved
in the meta-analysis.
Even a brief comparison of the characteristic of historical
or experimental balloons and currently used balloons demon-
strates the significant differences in their capacity, shape, and
time of treatment (Table 2). All of these differences could
influence the final weight loss, tolerance, and complications.
For example, we would like to highlight that, in 1992, the
Food and Drug Administration (FDA) withdrew approval
for the gastric bubble because of significant complications
and weight loss recidivism [10]. It is also interesting that in
one of the included studies (Geliebter), the fluid-filled balloon
was made from a breast implant!
The authors also performed a comparison between fluid-
filled and air-filled balloons. However, we should be aware
that all types of air-filled balloons involved in the analysis
were historical, among them the Garren-Edward gastric bub-
ble and the Ballobes bubble. On the opposite side of the anal-
ysis were fluid-filled balloons which are used today (Orbera
intragastric balloon, ReShape dual intragastric balloon). We
would also mention that air-filled balloons are also in use
Table 1 Studies included in the meta-analysis with historical or











1988 23 Air-filled Garren-Edward
gastric
bubble





1989 24 Air-filled Ballobes bubble





1990 56 Air-filled Ballobes bubble
7. Geliebter [8] 1991 40 Fluid-filled Breast implant
8. Rigaud [9] 1995 20 Air-filled Ballobes bubble
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(Heliosphere BAG [11]) nowadays; however, they also differ
in shape, capacity, and treatment period from historical de-
vices. In fact, the authors compared historical types of bal-
loons with modern ones.
To conclude, we ask ourselves whether, on the basis of
such an analysis, it is possible to decide which type of treat-
ment could and should be offered to patients.
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Years of use 1984–1992 1988–??? ??? 1991–now 2007–now 2004–now
Fulfillment Air Air Fluid Fluid Fluid Air
Capacity 200–220 mL 500 mL 300 mL 400–700 mL 900 mL 600–960 mL
Shape Cylindrical Oval ??? Spherical Bi-lobal Spherical
Treatment period 4 months 3–4 months 3 months 6 months 6 months 6 months
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